# SGLT2 Inhibition Improves Vascular Function in Patients with Type 2 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sglt2-inhibition-improves-vascular-function-in-patients-with-type-2-diabetes-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Didde Kidmose Kristensen,Steffen Flindt Nielsen,Niels Henrik Buus,Frederik Husum Mårup,Jesper Nørgaard Bech,Camilla Lundgreen Duus,Frank Holden Mose |
| Citations | 0 |
| DOI | 10.1681/asn.20233411s1853b |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4397043756 |
| Type | conference-abstract |
| Year | 2023 |

## Paper authors

- [Frederik Husum Mårup](https://scholariq.org/researchers/frederik-husum-marup/)

## Paper journal

- [Journal of the American Society of Nephrology](https://scholariq.org/journals/journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)
- [Apelin-related biomedical research](https://scholariq.org/topics/apelin-related-biomedical-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.